Cite
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study.
MLA
Burden, A. D., et al. “Efficacy of Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares across Pre‐specified Patient Subgroups in the Effisayil 1 Study.” Experimental Dermatology, vol. 32, no. 8, Aug. 2023, pp. 1279–83. EBSCOhost, https://doi.org/10.1111/exd.14824.
APA
Burden, A. D., Okubo, Y., Zheng, M., Thaçi, D., van de Kerkhof, P., Hu, N., Quaresma, M., Thoma, C., & Choon, S. E. (2023). Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study. Experimental Dermatology, 32(8), 1279–1283. https://doi.org/10.1111/exd.14824
Chicago
Burden, A. D., Y. Okubo, M. Zheng, D. Thaçi, P. van de Kerkhof, N. Hu, M. Quaresma, C. Thoma, and S. E. Choon. 2023. “Efficacy of Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares across Pre‐specified Patient Subgroups in the Effisayil 1 Study.” Experimental Dermatology 32 (8): 1279–83. doi:10.1111/exd.14824.